Literature DB >> 10873623

Molecular cloning and characterization of a new insulin/IGF-like peptide of the nematode Caenorhabditis elegans.

T Kawano1, Y Ito, M Ishiguro, K Takuwa, T Nakajima, Y Kimura.   

Abstract

Diapause, aging, and fat accumulation in Caenorhabditis elegans are regulated by DAF-2, a homolog of mammalian insulin/insulin-like growth factor-I (IGF-I) receptors. We have cloned and characterized a C. elegans gene encoding a new insulin/IGF-like peptide. The gene containing three exons encodes a precursor protein 95 residue long. Although the putative precursor contains a signal peptide, B chain, C peptide, and A chain like the preproinsulin, the mature peptide consists of one polypeptide-like IGF. The predicted tertiary structure seems similar to crystal structure of insulin. Therefore, the peptide may be a hybrid molecule of insulin and IGF. The peptide expression was detected at the embryonic and several larval stages. Disruption of the peptide production led to an extended life span like the daf-2 mutation, suggesting that the peptide should be one of the ligands of the DAF-2. This is the first description of the peptide that mediates animal longevity. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873623     DOI: 10.1006/bbrc.2000.2971

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

1.  Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family.

Authors:  S B Pierce; M Costa; R Wisotzkey; S Devadhar; S A Homburger; A R Buchman; K C Ferguson; J Heller; D M Platt; A A Pasquinelli; L X Liu; S K Doberstein; G Ruvkun
Journal:  Genes Dev       Date:  2001-03-15       Impact factor: 11.361

2.  Human longevity and variation in GH/IGF-1/insulin signaling, DNA damage signaling and repair and pro/antioxidant pathway genes: cross sectional and longitudinal studies.

Authors:  Mette Soerensen; Serena Dato; Qihua Tan; Mikael Thinggaard; Rabea Kleindorp; Marian Beekman; Rune Jacobsen; H Eka D Suchiman; Anton J M de Craen; Rudi G J Westendorp; Stefan Schreiber; Tinna Stevnsner; Vilhelm A Bohr; P Eline Slagboom; Almut Nebel; James W Vaupel; Kaare Christensen; Matt McGue; Lene Christiansen
Journal:  Exp Gerontol       Date:  2012-03-03       Impact factor: 4.032

Review 3.  Developmental decisions: balancing genetics and the environment by C. elegans.

Authors:  David V Tobin; Richard Mako Saito
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

4.  A systematic RNAi screen for longevity genes in C. elegans.

Authors:  Benjamin Hamilton; Yuqing Dong; Mami Shindo; Wenyu Liu; Ian Odell; Gary Ruvkun; Siu Sylvia Lee
Journal:  Genes Dev       Date:  2005-07-01       Impact factor: 11.361

5.  The EGL-3 proprotein convertase regulates mechanosensory responses of Caenorhabditis elegans.

Authors:  J Kass; T C Jacob; P Kim; J M Kaplan
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

Review 6.  Integration of diverse inputs in the regulation of Caenorhabditis elegans DAF-16/FOXO.

Authors:  Jessica N Landis; Coleen T Murphy
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

Review 7.  Neuropeptides.

Authors:  Chris Li; Kyuhyung Kim
Journal:  WormBook       Date:  2008-09-25

8.  Life span extensions associated with upregulation of gene expression of antioxidant enzymes in Caenorhabdms elegans; studies of mutation in the AGE-1, PI3 kinase homologue and short-term exposure to hyperoxia.

Authors:  Y Honda; S Honda
Journal:  J Am Aging Assoc       Date:  2001-10

9.  Life span extensions associated with upregulation of gene expression of antioxidant enzymes in Caenorhabditis elegans; studies of mutation in the age-1, PI3 kinase homologue and short-term exposure to hyperoxia.

Authors:  Y Honda; S Honda
Journal:  J Am Aging Assoc       Date:  2002-01

10.  The EGL-21 carboxypeptidase E facilitates acetylcholine release at Caenorhabditis elegans neuromuscular junctions.

Authors:  Tija C Jacob; Joshua M Kaplan
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.